Authors


Mark Leykin

Latest:

Single-Use Technology in Parenteral Fill/Finish

Application of single-use technology in a parenteral facility for syringe filling.


Kate Achtien

Latest:

ZFN Technology Advances Biopharmaceutical Manufacturing

Applications of ZFN technology in biopharmaceutical cell-line engineering.


Geoff Carr

Latest:

Black Specks in Tablet Stability Samples

A study of root cause in stability samples suggests the need for tighter control of the sodium lauryl sulfate manufacturing processes.


Eurofins

Latest:

Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies

Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.


Stacy L. Springs

Latest:

Correlating Product Lifecycle and Manufacturing Site Characteristics with Critical-to-Quality Product Deviations

MIT survey results address product and site characteristics that statistically correlate with quality performance.


Mansoor A. Khan, RPh, PhD

Latest:

Effect of Extragranular Microcrystalline Cellulose on Compaction, Surface Roughness, and In Vitro Dissolution of a Self-Nanoemulsified Solid Dosage Form of Ubiquinone

Powdered self-emulsified dosage forms provide an attractive alternative to filled-capsule preparations, but the selection of a proper excipient is crucial.


Andrea Detroy

Latest:

Single-Use Technology in Parenteral Fill/Finish

Application of single-use technology in a parenteral facility for syringe filling.


Michael R. Thompson

Latest:

Foam Granulation

The authors review developments in wet granulation using a twin-screw extruder.


Norman Randall

Latest:

Certificates of Test - What are the European GMP Requirements?

This article examines European differences in GMP requirements for the acceptance of Certificates of Tests. The authors look at how pharmaceutical manufacturers can address the issues and suggest a US-compatible framework for GMPs that could be incorporated into EU requirements.


Ranjeet Patil

Latest:

Single-Use Redundant Filtration

The authors describe a new assembly for bulk and final drug product filling operations.


Susanne Hibler

Latest:

Freeze-Drying Process Optimisation for a Small Molecule

For true freeze-drying cycle optimisation, information on the maximum allowable product temperature during primary drying is required.



Christian Matz

Latest:

Single-Use Technology in Parenteral Fill/Finish

Application of single-use technology in a parenteral facility for syringe filling.


Ross W. Acucena

Latest:

Single-Use Technology in Parenteral Fill/Finish

Application of single-use technology in a parenteral facility for syringe filling.



Scott Stern

Latest:

Correlating Product Lifecycle and Manufacturing Site Characteristics with Critical-to-Quality Product Deviations

MIT survey results address product and site characteristics that statistically correlate with quality performance.


Nick Yankauskas

Latest:

A New Approach to Forced Degradation Studies Using Anhydrous Conditions

In this article, the authors demonstrate that a normal-phase chromatographic method was stability-indicating for a water-sensitive prodrug. The stress conditions using aqueous and non-aqueous conditions were also compared to understand the information obtained with each approach.


Dr N. Udupa

Latest:

Fixed-Dose Combinations

Fixed-dose combinations (FDCs) reduce the number of pills that must be taken, but they have also been a topic of concern, mainly because of the perceived potential for increased adverse events. PTE speaks with researchers to explore the benefits and concerns of FDCs.


Matt Bundenthal

Latest:

Understanding Containment for Tableting

Risk levels should be considered when designing containment for pharmaceutical tableting equipment to enhance operator safety.


Alconox

Latest:

Applications in Pharmaceutical Manufacturing

The use of aqueous cleaning in pharmaceutical manufacturing can provide numerous benefits in terms of effectiveness, minimal surface residue, and easier cleaning validation.


Graham Cook

Latest:

Implementation of ICH Q3D Elemental Impurities Guideline: Challenges and Opportunities

Assessing risk factors is key to implementing the new ICH Q3D guidelines for elemental impurities.


Jonathan Burd

Latest:

Documentary Evidence

A look at the role of document management in the product life-cycle and how this can lead to the effective use of CTDs and e-CTDs when compiling compulsory regulatory submissions...


Frank Diana

Latest:

Analytical Method Comparability in Registration and Post-Approval Stages: A Risk-Based Approach

A risk-based approach is recommended for analytical method comparability for HPLC assay and impurities methods.


Paula R. Katz

Latest:

Deficiencies Found in API Inspections

PIC/S reviews deficiencies found during inspections of API manufacturing facilities, harmonizes GMP standards, and provides training for inspectors worldwide.


James Calvin

Latest:

Multilayer Tablets: A Piece Of Cake?

Multilayer tablets: A piece of cake or just a passing fad? We bring experts together to find out.


Abdennour Bouhroum

Latest:

Using Analytical Techniques to Examine Tablet Sticking

Analytical tests, correlated with statistical techniques, are used to predict material behavior.


Bruce Acken

Latest:

Early Development GMPs for Stability (Part IV)

IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development, with a focus on stability.


Alicia Mozzachio

Latest:

Deficiencies Found in API Inspections

PIC/S reviews deficiencies found during inspections of API manufacturing facilities, harmonizes GMP standards, and provides training for inspectors worldwide.


Lane Christensen

Latest:

Regulatory Considerations for Controlled Correspondence Related to Generic Drug Chemistry

An analysis of controlled correspondence between generic-drug manufacturers and FDA reveals patterns in questions about specific drug chemistry topics and the response to information provided in FDA guidance documents.


Paul Curry

Latest:

Early Development GMPs for Stability (Part IV)

IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development, with a focus on stability.